wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q44778300-194C65BD-5B8D-44BA-A0F2-0C7FE9D8EE9B
Q44778300-194C65BD-5B8D-44BA-A0F2-0C7FE9D8EE9B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44778300-194C65BD-5B8D-44BA-A0F2-0C7FE9D8EE9B
Low daily dosage of interferon for 1 year after HCV-related end-therapy response. A randomized-controlled study.
P2860
Q44778300-194C65BD-5B8D-44BA-A0F2-0C7FE9D8EE9B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44778300-194C65BD-5B8D-44BA-A0F2-0C7FE9D8EE9B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
da93738df30da014798f15936346ab13b32d57f0
P2860
Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers.